Bone Marrow Plasma Cell Assessment before Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Figure 5
Progression-free survival according to premobilization bone marrow plasma cells in serologic subgroups. (a) Progression-free survival in the serologic CR group and (b) Progression-free survival in the serologic non-CR group.
